These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35650422)

  • 1. A nuclease inhibitor for neurodegeneration.
    Eccleston A
    Nat Rev Drug Discov; 2022 Jul; 21(7):493. PubMed ID: 35650422
    [No Abstract]   [Full Text] [Related]  

  • 2. Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications.
    Guo W; Stoklund Dittlau K; Van Den Bosch L
    Semin Cell Dev Biol; 2020 Mar; 99():133-150. PubMed ID: 31542222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting protein aggregation in neurodegeneration--lessons from polyglutamine disorders.
    Weydt P; La Spada AR
    Expert Opin Ther Targets; 2006 Aug; 10(4):505-13. PubMed ID: 16848688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell death assays for neurodegenerative disease drug discovery.
    Linsley JW; Reisine T; Finkbeiner S
    Expert Opin Drug Discov; 2019 Sep; 14(9):901-913. PubMed ID: 31179783
    [No Abstract]   [Full Text] [Related]  

  • 5. Teaching old drugs new tricks. Meeting of the Neurodegeneration Drug Screening Consortium, 7-8 April 2002, Washington, DC, USA.
    Heemskerk J; Tobin AJ; Bain LJ
    Trends Neurosci; 2002 Oct; 25(10):494-6. PubMed ID: 12220871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of insulin resistance in the neurodegeneration.
    Stefanelli M; Martocchia A; De Marinis EA; Falaschi GM; Romano G; Rufo M; Falaschi P
    Recent Pat CNS Drug Discov; 2014 Apr; 9(1):54-63. PubMed ID: 24724584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule-targeting agents and neurodegeneration.
    Boiarska Z; Passarella D
    Drug Discov Today; 2021 Feb; 26(2):604-615. PubMed ID: 33279455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxidation in neurodegeneration.
    Peña-Bautista C; Vento M; Baquero M; Cháfer-Pericás C
    Clin Chim Acta; 2019 Oct; 497():178-188. PubMed ID: 31377127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuins as possible targets in neurodegenerative diseases.
    Donmez G
    Curr Drug Targets; 2013 Jun; 14(6):644-7. PubMed ID: 23410123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of antioxidants in the management of neurodegenerative disorders: A literature review.
    Panahi Y; Rajaee SM; Johnston TP; Sahebkar A
    J Cell Biochem; 2019 Mar; 120(3):2742-2748. PubMed ID: 29219206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Emancipated' biotechs offer new drugs for neurodegeneration.
    Basu P
    Nat Med; 2003 Aug; 9(8):981. PubMed ID: 12894143
    [No Abstract]   [Full Text] [Related]  

  • 12. Could PKR inhibition modulate human neurodegeneration?
    Hugon J; Paquet C; Chang RC
    Expert Rev Neurother; 2009 Oct; 9(10):1455-7. PubMed ID: 19831834
    [No Abstract]   [Full Text] [Related]  

  • 13. Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation.
    Martinez-Vicente M
    Semin Cell Dev Biol; 2015 Apr; 40():115-26. PubMed ID: 25843774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America.
    Rao KSJ; Britton GB; Rocha Arrieta LL; Garcia-Cairasco N; Lazarowski A; Palacios A; Camins Espuny A; Maccioni RB
    J Alzheimers Dis; 2021; 82(s1):S1-S4. PubMed ID: 34092644
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular mechanisms of neurodegeneration.
    Dormann D
    Semin Cell Dev Biol; 2020 Mar; 99():131-132. PubMed ID: 31902626
    [No Abstract]   [Full Text] [Related]  

  • 16. How can we address the controversies surrounding the use of NSAIDS in neurodegeneration?
    Ling QL; Murdoch E; Ruan KH
    Future Med Chem; 2016 Jul; 8(11):1153-5. PubMed ID: 27357618
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug Discovery for Neurodegeneration - inaugural Alzheimer's Drug Discovery Foundation meeting.
    Fallon L
    IDrugs; 2007 Apr; 10(4):233-6. PubMed ID: 17390241
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological Approaches Targeting Brain Cell Survival in the Context of Neurodegeneration and Potential Treatment Strategies.
    Aliev G
    Curr Neuropharmacol; 2019; 17(3):198-200. PubMed ID: 30592253
    [No Abstract]   [Full Text] [Related]  

  • 19. The antiapoptotic activity of melatonin in neurodegenerative diseases.
    Wang X
    CNS Neurosci Ther; 2009; 15(4):345-57. PubMed ID: 19818070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic strategies in neural diseases uncover unexpected disease connections: from neurodegeneration and addiction to pain and depression.
    Herradón G
    Curr Pharm Des; 2011; 17(5):408-9. PubMed ID: 21375479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.